Success Metrics

Clinical Success Rate
71.4%

Based on 5 completed trials

Completion Rate
71%(5/7)
Active Trials
1(6%)
Results Posted
0%(0 trials)
Terminated
2(11%)

Phase Distribution

Ph phase_2
2
11%
Ph not_applicable
5
28%
Ph phase_3
4
22%
Ph phase_4
3
17%

Phase Distribution

0

Early Stage

2

Mid Stage

7

Late Stage

Phase Distribution14 total trials
Phase 2Efficacy & side effects
2(14.3%)
Phase 3Large-scale testing
4(28.6%)
Phase 4Post-market surveillance
3(21.4%)
N/ANon-phased studies
5(35.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

1

trials recruiting

Total Trials

18

all time

Status Distribution
Active(1)
Completed(5)
Terminated(2)
Other(10)

Detailed Status

unknown10
Completed5
Terminated2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
18
Active
1
Success Rate
71.4%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (14.3%)
Phase 34 (28.6%)
Phase 43 (21.4%)
N/A5 (35.7%)

Trials by Status

recruiting16%
completed528%
unknown1056%
terminated211%

Recent Activity

Clinical Trials (18)

Showing 18 of 18 trials
NCT04800497

The Role Of Circulating Tumor Cells As Markers Of Advanced Disease And Prognosis In HCC

Recruiting
NCT02866344Not Applicable

Resection Versus Microwave Ablation for Resectable Colorectal Cancer Liver Metastases

Terminated
NCT02192671Phase 3

HR Versus RFA for HCC in Patients With PHT

Unknown
NCT03971201Phase 2

A Randomized Phase II Trial of Surgery Plus Sorafenib vs. Sorafenib Alone for Hepatocellular Cancer (HCC) With Portal Vein Invasion

Unknown
NCT02169765Phase 3

HR Versus RFA for Early Stage HCC

Unknown
NCT01409499Phase 4

Palliative Treatments for Patients With Advanced Hepatocellular Carcinoma (HCC)

Completed
NCT03469479Phase 3

Neoadjuvant HAIC for Resectable Hepatocellular Carcinoma Beyond Milan Criteria

Unknown
NCT03191123Not Applicable

Resection Versus Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma With Solitary Huge Tumor

Unknown
NCT03476421

R1vascular Hepatectomy for HCC Patients

Completed
NCT02616926Not Applicable

Hepatic Resection Versus TACE+RFA for BCLC Stage B Hepatocellular Carcinoma

Unknown
NCT02615665

Intratumoral CD3+ and NKp46+ Cells in Colorectal Liver Metastases

Completed
NCT02482909Not Applicable

A Study Comparing Radiofrequency Ablation and Hepatic Resection for Hepatocellular Carcinoma

Terminated
NCT02056028

Bile Leak After Liver Surgery

Completed
NCT00610636Phase 3

Treatment Outcomes of Hepatic Metastasis After FOLFOX-4 Therapy

Unknown
NCT01387061Not Applicable

Resection for Multiple Hepatocellular Carcinomas (HCC)

Completed
NCT01351194Phase 4

Radiofrequency Ablation Versus Hepatic Resection for the Treatment of Hepatocellular Carcinomas Smaller Than 2 cm

Unknown
NCT01350206Phase 4

Hepatic Resection Versus Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma Complicated by Portal Vein Tumor Thrombosis

Unknown
NCT00172159Phase 2

Influence of Neoadjuvant Therapy on the Resectability of Hepatic Metastases From Colorectal Cancers

Unknown

All 18 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
18